Back
Cassava Sciences Vs. Novartis AG Industry Stock Comparison
Sell
16
SAVA
Cassava Sciences
Last Price:
$1.72
Seasonality Move:
10.89%
Buy
59
NVSEF
Novartis AG
Last Price:
$107.55
Seasonality Move:
5.97%
Sell
16
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
-
The current Cassava Sciences [SAVA] share price is $1.75. The Score for SAVA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
SAVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
59
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.55. The Score for NVSEF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $1.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.
SAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 28.43 | Sell |
Chaikin Money Flow: | -3713851 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.33 - 2.87) | Sell |
Bollinger Bands (100): | (-2.13 - 17.07) | Sell |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.55 | Buy |
Relative Strength Index (14 RSI): | 45.62 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.25 - 114.29) | Sell |
Bollinger Bands (100): | (98.5 - 109.54) | Buy |
SAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.54 | Sell |
20-day SMA: | 2.6 | Sell |
50-day SMA: | 2.54 | Sell |
200-day SMA: | 15.28 | Sell |
8-day EMA: | 2.39 | Sell |
20-day EMA: | 2.54 | Sell |
50-day EMA: | 3.56 | Sell |
200-day EMA: | 12.35 | Sell |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.73 | Sell |
20-day SMA: | 111.57 | Sell |
50-day SMA: | 106.51 | Buy |
200-day SMA: | 106.88 | Buy |
8-day EMA: | 111.99 | Sell |
20-day EMA: | 110.88 | Sell |
50-day EMA: | 107.89 | Sell |
200-day EMA: | 104.88 | Buy |
Cassava Sciences Earnings Growth & SAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and a decrease next year of $1.54 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cassava Sciences Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |